Between November 29th and 30th, our Chief Executive Officer Bárbara Gomes has made her way over to Biofit 2022 in Strasbourg to present our capacities.

During the event, Nuno Prego Ramos, CEO of our associate CellmAbs, talked about IP licensing issues for start-up companies and shared the strategies of the company to overcome these issues.
This talk was part of the kick –off meeting of LEAP-Bio project, funded by European Commission. LEAP-BIO aims to develop an early-stage focused IP licensing intermediary service for biopharma SMEs and startup companies and is co-lead by our associate Instituto de Medicina Molecular.